181 related articles for article (PubMed ID: 32660532)
1. A case report of an intermediate phenotype between congenital myasthenic syndrome and D-2- and L-2-hydroxyglutaric aciduria due to novel SLC25A1 variants.
Li W; Zhang M; Zhang L; Shi Y; Zhao L; Wu B; Li X; Zhou S
BMC Neurol; 2020 Jul; 20(1):278. PubMed ID: 32660532
[TBL] [Abstract][Full Text] [Related]
2. [Congenital myasthenic syndrome related to SLC25A1 gene variant: two cases report and literature review].
Li WH; Wu BB; Zhou SZ
Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):42-46. PubMed ID: 33397003
[No Abstract] [Full Text] [Related]
3. Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant.
Balaraju S; Töpf A; McMacken G; Kumar VP; Pechmann A; Roper H; Vengalil S; Polavarapu K; Nashi S; Mahajan NP; Barbosa IA; Deshpande C; Taylor RW; Cossins J; Beeson D; Laurie S; Kirschner J; Horvath R; McFarland R; Nalini A; Lochmüller H
Eur J Hum Genet; 2020 Mar; 28(3):373-377. PubMed ID: 31527857
[TBL] [Abstract][Full Text] [Related]
4. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria.
Nota B; Struys EA; Pop A; Jansen EE; Fernandez Ojeda MR; Kanhai WA; Kranendijk M; van Dooren SJ; Bevova MR; Sistermans EA; Nieuwint AW; Barth M; Ben-Omran T; Hoffmann GF; de Lonlay P; McDonald MT; Meberg A; Muntau AC; Nuoffer JM; Parini R; Read MH; Renneberg A; Santer R; Strahleck T; van Schaftingen E; van der Knaap MS; Jakobs C; Salomons GS
Am J Hum Genet; 2013 Apr; 92(4):627-31. PubMed ID: 23561848
[TBL] [Abstract][Full Text] [Related]
5. Missense mutations in SLC25A1 are associated with congenital myasthenic syndrome type 23.
Al-Futaisi A; Ahmad F; Al-Kasbi G; Al-Thihli K; Koul R; Al-Maawali A
Clin Genet; 2020 Apr; 97(4):666-667. PubMed ID: 31808147
[No Abstract] [Full Text] [Related]
6. An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants.
Pop A; Williams M; Struys EA; Monné M; Jansen EEW; De Grassi A; Kanhai WA; Scarcia P; Ojeda MRF; Porcelli V; van Dooren SJM; Lennertz P; Nota B; Abdenur JE; Coman D; Das AM; El-Gharbawy A; Nuoffer JM; Polic B; Santer R; Weinhold N; Zuccarelli B; Palmieri F; Palmieri L; Salomons GS
J Inherit Metab Dis; 2018 Mar; 41(2):169-180. PubMed ID: 29238895
[TBL] [Abstract][Full Text] [Related]
7. Congenital Myasthenic Syndrome Associated With SLC25A1 Gene Variant: The First Reported Case in Saudi Arabia.
Alzahrani AYB; Alghamdi LSA; Alghamdi HAM; Hassan AF; Alsehemi MA
Cureus; 2023 Mar; 15(3):e35808. PubMed ID: 37033560
[TBL] [Abstract][Full Text] [Related]
8. A novel homozygous SLC25A1 mutation with impaired mitochondrial complex V: Possible phenotypic expansion.
Cohen I; Staretz-Chacham O; Wormser O; Perez Y; Saada A; Kadir R; Birk OS
Am J Med Genet A; 2018 Feb; 176(2):330-336. PubMed ID: 29226520
[TBL] [Abstract][Full Text] [Related]
9. Manifestation of recessive combined D-2-, L-2-hydroxyglutaric aciduria in combination with 22q11.2 deletion syndrome.
Eguchi M; Ozaki E; Yamauchi T; Ohta M; Higaki T; Masuda K; Imoto I; Ishii E; Eguchi-Ishimae M
Am J Med Genet A; 2018 Feb; 176(2):351-358. PubMed ID: 29265763
[TBL] [Abstract][Full Text] [Related]
10. Expanding the Clinical Spectrum of Mitochondrial Citrate Carrier (SLC25A1) Deficiency: Facial Dysmorphism in Siblings with Epileptic Encephalopathy and Combined D,L-2-Hydroxyglutaric Aciduria.
Prasun P; Young S; Salomons G; Werneke A; Jiang YH; Struys E; Paige M; Avantaggiati ML; McDonald M
JIMD Rep; 2015; 19():111-5. PubMed ID: 25614306
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Mutations Can Alter Neuromuscular Transmission in Congenital Myasthenic Syndrome and Mitochondrial Disease.
O'Connor K; Spendiff S; Lochmüller H; Horvath R
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239850
[TBL] [Abstract][Full Text] [Related]
12. A novel compound heterozygous mutation in a Chinese boy with L-2-hydroxyglutaric aciduria: a case study.
Tai H; Zhang Z
BMC Neurol; 2015 Jul; 15():117. PubMed ID: 26208971
[TBL] [Abstract][Full Text] [Related]
13. Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment.
Mühlhausen C; Salomons GS; Lukacs Z; Struys EA; van der Knaap MS; Ullrich K; Santer R
J Inherit Metab Dis; 2014 Sep; 37(5):775-81. PubMed ID: 24687295
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission.
Chaouch A; Porcelli V; Cox D; Edvardson S; Scarcia P; De Grassi A; Pierri CL; Cossins J; Laval SH; Griffin H; Müller JS; Evangelista T; Töpf A; Abicht A; Huebner A; von der Hagen M; Bushby K; Straub V; Horvath R; Elpeleg O; Palace J; Senderek J; Beeson D; Palmieri L; Lochmüller H
J Neuromuscul Dis; 2014; 1(1):75-90. PubMed ID: 26870663
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic mutations of the human mitochondrial citrate carrier SLC25A1 lead to impaired citrate export required for lipid, dolichol, ubiquinone and sterol synthesis.
Majd H; King MS; Smith AC; Kunji ERS
Biochim Biophys Acta Bioenerg; 2018 Jan; 1859(1):1-7. PubMed ID: 29031613
[TBL] [Abstract][Full Text] [Related]
16. VAMP1-Related Congenital Myasthenic Syndrome: A Case Report and Literature Review.
Yıldırım M; Yarenci GB; Genç MB; Uçar Çİ; Bayav S; Tekin MN; Bektaş Ö; Teber S
Neuropediatrics; 2024 Jun; 55(3):200-204. PubMed ID: 38531369
[TBL] [Abstract][Full Text] [Related]
17. Severe Neonatal Presentation of Mitochondrial Citrate Carrier (SLC25A1) Deficiency.
Smith A; McBride S; Marcadier JL; Michaud J; Al-Dirbashi OY; Schwartzentruber J; Beaulieu CL; Katz SL; ; Majewski J; Bulman DE; Geraghty MT; Harper ME; Chakraborty P; Lines MA
JIMD Rep; 2016; 30():73-79. PubMed ID: 27306203
[TBL] [Abstract][Full Text] [Related]
18. A new patient with congenital myasthenic syndrome type 20 due to compound heterozygous missense SLC5A7 variants suggests trends in genotype-phenotype correlation.
Vlckova M; Prchalova D; Zimmermann P; Haberlova J; Bendova S; Moslerova V; Stranecky V; Sedlacek Z; Hancarova M
Mol Genet Genomic Med; 2023 Jun; 11(6):e2154. PubMed ID: 36840359
[TBL] [Abstract][Full Text] [Related]
19. D-2-hydroxyglutaric aciduria Type I: Functional analysis of D2HGDH missense variants.
Pop A; Struys EA; Jansen EEW; Fernandez MR; Kanhai WA; van Dooren SJM; Ozturk S; van Oostendorp J; Lennertz P; Kranendijk M; van der Knaap MS; Gibson KM; van Schaftingen E; Salomons GS
Hum Mutat; 2019 Jul; 40(7):975-982. PubMed ID: 30908763
[TBL] [Abstract][Full Text] [Related]
20. Two novel L2HGDH mutations identified in a rare Chinese family with L-2-hydroxyglutaric aciduria.
Peng W; Ma XW; Yang X; Zhang WQ; Yan L; Wang YX; Liu X; Wang Y; Feng ZC
BMC Med Genet; 2018 Sep; 19(1):167. PubMed ID: 30217188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
